1. Home
  2. TRDA vs MSBI Comparison

TRDA vs MSBI Comparison

Compare TRDA & MSBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$11.70

Market Cap

404.4M

Sector

Health Care

ML Signal

HOLD

Logo Midland States Bancorp Inc.

MSBI

Midland States Bancorp Inc.

N/A

Current Price

$24.13

Market Cap

456.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TRDA
MSBI
Founded
2016
1881
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
404.4M
456.2M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
TRDA
MSBI
Price
$11.70
$24.13
Analyst Decision
Strong Buy
Hold
Analyst Count
1
3
Target Price
$20.00
$19.67
AVG Volume (30 Days)
200.0K
165.5K
Earning Date
02-26-2026
01-22-2026
Dividend Yield
N/A
5.32%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$61,520,000.00
$210,718,000.00
Revenue This Year
N/A
$28.14
Revenue Next Year
$3.14
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.93
$14.24
52 Week High
$14.27
$25.05

Technical Indicators

Market Signals
Indicator
TRDA
MSBI
Relative Strength Index (RSI) 64.79 63.71
Support Level $10.34 $21.97
Resistance Level $11.49 $24.57
Average True Range (ATR) 0.72 0.66
MACD 0.08 0.05
Stochastic Oscillator 83.51 56.59

Price Performance

Historical Comparison
TRDA
MSBI

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment, which generates the majority of the revenue, provides financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage, and other consumer loan products; commercial equipment financing, etc. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Corporate segment includes the holding company's financing and investment activities, administrative expenses.

Share on Social Networks: